08.08.2020

WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?

WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda? aliu Sat, 08/08/2020 - 06:38
08.07.2020

WCLC: Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%

WCLC: Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26% chelfand Fri, 08/07/2020 - 18:31
08.07.2020

Roche gets a green light to challenge Biogen, Novartis with SMA med Evrysdi

Roche gets a green light to challenge Biogen, Novartis with SMA med Evrysdi esagonowsky Fri, 08/07/2020 - 14:39
08.07.2020

Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan

Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan aliu Fri, 08/07/2020 - 10:46
08.07.2020

Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir

Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir esagonowsky Fri, 08/07/2020 - 10:36
08.07.2020

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan fkansteiner Fri, 08/07/2020 - 09:36
08.07.2020

FiercePharmaAsia—COVID vax deals by AstraZeneca in China, Pfizer-BioNTech in Japan; new Legend CEO

FiercePharmaAsia—COVID vax deals by AstraZeneca in China, Pfizer-BioNTech in Japan; new Legend CEO aliu Fri, 08/07/2020 - 08:57
08.07.2020

Roche swings and misses with another Tecentriq-chemo combo in tough-to-treat breast cancer

Roche swings and misses with another Tecentriq-chemo combo in tough-to-treat breast cancer chelfand Fri, 08/07/2020 - 03:03
08.06.2020

Alexion hires first chief diversity officer, following pharma peers and social sentiment

Alexion hires first chief diversity officer, following pharma peers and social sentiment beth.bulik Thu, 08/06/2020 - 10:59
08.06.2020

Analysts to Bristol Myers Squibb: Can I-O hit Opdivo really return to growth?

Analysts to Bristol Myers Squibb: Can I-O hit Opdivo really return to growth? arlene.weintraub Thu, 08/06/2020 - 10:51